The FDA has granted marketing authorization to CT-132 for the preventive treatment of episodic migraine in patients aged 18 years and older.

The Nerivio® REN wearable provides a clinically proven, drug-free solution for both acute and preventive treatment of migraine in adults and children aged 8 and older.

Children and adolescents treated with fremanezumab experienced fewer migraine and headache days compared with placebo, according to an abstract presented at the American Academy of Neurology Annual ...

For the first time in 30 years, a new drug class known as the CGRP-Antagonists (calcitonin gene-related peptide) has emerged. These medications are proving to be highly effective for migraine ...

The following is a summary of “A National Cross-Sectional Survey on Real-World Experiences of Calcitonin Gene-Related Peptide ...

Migraine disease affects millions of Americans, but treatments often cause side effects that hinder sufferers' ability to function.

Lasmiditan is a promising treatment for menstrual migraine, offering sustained pain relief comparable to or exceeding that of triptans. However, further research is needed to fully assess its safety ...

Helper. It uses dry air to cool the nasal passage and helps stop the activation of the part of the brain that is turned on during a migraine.

At AAN 2025, three posters presented the sustained long-term efficacy and real-world impact of Lundbeck’s Vyepti for migraine ...

But drug-free treatment options are making it easier to manage migraine – without the debilitating side effects. Recently. Neurologist and Migraine Specialist, Dr. Aliya Frederick, along with ...